LONG GROVE PHARMACEUTICALS
News & Events
LONG GROVE PHARMACEUTICALS
News & Events
View Our Latest News and
See Our Schedule of Events Below
Upcoming Events
In the News
Product Labeling
December 4, 2024
Enhancing Patient Safety Through Critical Drug Label Improvements
Premix Norepinephrine
October 16, 2024
Premier and Long Grove Partner to Increase Norepinephrine IV Bag Supply
Premix Norepinephrine
October 2024
Premier, Long Grove join forces to increase supply of norepinephrine IV bags
Premix Norepinephrine
October 3, 2024
Premier, Long Grove join forces to increase supply of norepinephrine IV bags
Eribulin Mesylate Injection
August 2, 2024
FDA Gives Long Grove OK for Generic Halaven
Premix Vasopressin
July 24, 2024
Long Grove Receives FDA Nod for Premix Vasopressin
Sodium Bicarbonate
June 26, 2024
Long Grove to Launch Sodium Bicarbonate Injection
Premix Norepinephrine
June 12, 2024
Long Grove Pharmaceuticals Launches Premix Norepinephrine
Premix Edaravone Injection
May 8, 2024
Long Grove Gets FDA OK for Generic Radicava
AK-FLUOR® Fluorescein Injection, USP
November 16, 2023
Fluorescein Injection Available While Long Grove Pharmaceuticals Takes Over Manufacture
Premix Norepinephrine Bitartrate in 0.9% Sodium Chloride
May 10, 2023
Long Grove Pharmaceuticals Secures Commercial Rights to Essential Critical Care Medication
Carboprost Tromethamine Injection, USP
January 12, 2023
Long Grove intros single-pack for generic Hemabate
Carboprost Tromethamine Injection, USP
January 12, 2023
Long Grove intros single-pack for generic Hemabate
Carboprost Tromethamine Injection, USP
January 10, 2023
Long Grove Pharmaceuticals Launches Single Pack for Carboprost Tromethamine Injection, USP
Press Releases
September | 2024
Premier, Inc. and Long Grove Pharmaceuticals Join Forces to Increase Supply of Norepinephrine IV Bags
July | 2024
Long Grove Pharmaceuticals Receives FDA Approval for Generic Eribulin Mesylate Injection
May | 2024
Long Grove Pharmaceuticals Receives FDA Approval for Generic Edaravone Injection
May | 2024
Long Grove will soon offer Premix Vasopressin to help relieve stress on critical care
December | 2023
Long Grove Pharmaceuticals Launches Chemotherapy Medication in Partnership with Sunny Pharmtech
May | 2023
Long Grove Pharmaceuticals Secures Commercial Rights to Premix Norepinephrine in 0.9% Sodium Chloride
January | 2023
Long Grove Pharmaceuticals Launches First and Only Single-Pack Presentation for Carboprost Tromethamine Injection, USP
November | 2022
Long Grove Pharmaceuticals Launches Carboprost Tromethamine Injection, USP
September | 2024
Premier, Inc. and Long Grove Pharmaceuticals Join Forces to Increase Supply of Norepinephrine IV Bags
July | 2024
Long Grove Pharmaceuticals Receives FDA Approval for Generic Eribulin Mesylate Injection
May | 2024
Long Grove Pharmaceuticals Receives FDA Approval for Generic Edaravone Injection
May | 2024
Long Grove will soon offer Premix Vasopressin to help relieve stress on critical care
December | 2023
Long Grove Pharmaceuticals Launches Chemotherapy Medication in Partnership with Sunny Pharmtech
May | 2023
Long Grove Pharmaceuticals Secures Commercial Rights to Premix Norepinephrine in 0.9% Sodium Chloride
January | 2023
Long Grove Pharmaceuticals Launches First and Only Single-Pack Presentation for Carboprost Tromethamine Injection, USP
July | 2022
Long Grove Pharmaceuticals Launches Triamcinolone Acetonide Injectable Suspension, USP
April | 2022
Long Grove Pharmaceuticals® Launches as New Leader in Specialized Generics
